Health Condition 1: C50- Malignant neoplasm of breast
Conditions
Interventions
Intervention1: Inj Indocyanine green Intravenous and Intradermal: â?¢ In one arm we will use fluorescein dye 2ml 20% iv injected at the time of induction of anaesthesia and 0.1 ml intradermally dilut
Sponsors
Department Of Surgical Disciplines
Eligibility
Inclusion criteria
Inclusion criteria: All ladies with early breast cancer proven by histopathology
Exclusion criteria
Exclusion criteria: 1.Ladies not giving consent 2.Palpable axillary lymph nodes 3.Patient with distant metastasis 4.Inflammatory carcinoma breast 5.Patients with prior surgery to breast or axilla, scaring in axilla due to burns, trauma 6.Patients with multicentric and multifocal tumors and with h/o previous radiotherapy and/ chemotherapy. 7.Pregnant and lactating mothers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Identification of Sentinel Lymph node by Each dye in Breast Cancer PatientsTimepoint: Intraoperative | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To compare the direct cost in two arms of therapy and to perform a cost effective analysis. 2. To record the possible adverse effects occuring due to use of Indocyanine Green and FluoresceinTimepoint: 1 day | — |
Countries
India
Contacts
Public ContactDr Aakash Chauhan
All India Institute of Medical Sciences, New Delhi
Outcome results
None listed